Skip to NavigationSkip to content

Pharmafile - Research and Development News

Adcetris has long been one of Seagen’s top-selling and expanding products, and it has announced that the drug appeared successful especially when...
A new and experimental immunotherapy treatment has appeared successful in treating patients with multiple myeloma in an ongoing phase 1/2 clinical...
BioVie has announced positive results from two phase 2 trials which have been assessing NE3107’s efficacy in treating Parkinson’s Disease (PD) and...
San Francisco, US-based Nkarta have been assessing the power of natural killer (NK) cells in oncology treatments. The treatment is as-yet unproven...
Innovent Biologics, a biopharmaceutical company which develops, manufactures and commercialises medicines for the treatment of illnesses within the...
Amgen Inc’s new obesity drug has appeared promising in its small phase 1 trial, meaning they will be able to go ahead with a larger mid-stage trial...
Although researchers have previously always struggled to develop an efficient HIV vaccine, the results of a first-in-human clinical trial for a new...
GlaxoSmithKline (GSK) appear to be making some positive progress in their oncology department, with drugs for both myelofibrosis and endometrial...
Neuralink owner Elon Musk announced that he has submitted paperwork to the FDA which he hopes will allow Neuralink to undertake human trials in 2023...
In a world-first trial, the University of Sheffield and Sheffield Teaching Hospital NHS Foundation Trust will investigate the efficacy of stem cell...
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches